Nash, P., Tanaka, Y., Winthrop, K. L., Lee, E. B., Mariette, X., Curtis, J. R., . . . Wollenhaupt, J. Long-term safety of tofacitinib up to 9.5 years: A comprehensive integrated analysis of the rheumatoid arthritis clinical development programme. BMJ Publishing Group.
Chicago Style (17th ed.) CitationNash, Peter, et al. Long-term Safety of Tofacitinib Up to 9.5 Years: A Comprehensive Integrated Analysis of the Rheumatoid Arthritis Clinical Development Programme. BMJ Publishing Group.
MLA (9th ed.) CitationNash, Peter, et al. Long-term Safety of Tofacitinib Up to 9.5 Years: A Comprehensive Integrated Analysis of the Rheumatoid Arthritis Clinical Development Programme. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.